17. 多系統萎縮症 Multiple system atrophy Clinical trials / Disease details

臨床試験数 : 119 / 薬物数 : 138 - (DrugBank : 44) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 111

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04184063 (ClinicalTrials.gov)	September 16, 2019	29/7/2019	Study of NBMI Treatment in Patients With Atypical Parkinsons (PSP or MSA)	A Pilot Exploratory, Randomised, Placebo-controlled, Double Blinded, Cross-over , Phase 2a Study to ...	Progressive Supranuclear Palsy;Multiple System Atrophy	Drug: NBMI;Other: Placebo	EmeraMed	NULL	Completed	40 Years	85 Years	All	20	Phase 2	Slovenia
2	EUCTR2018-000506-34-SI (EUCTR)	04/02/2019	09/03/2018	EMERA006- A pilot, exploratory, randomised, placebo-controlled, double blinded, cross-over, Phase 2a ...	EMERA006- A pilot, exploratory, randomised, placebo-controlled, double blinded, cross-over, Phase 2a ...	PSP or MSA;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]	Product Name: NBMI Product Code: NBMI INN or Proposed INN: emeramide Other descriptive name: N1,N3-BIS( ...	NBMI Science Ltd.	NULL	Not Recruiting			Female: yes Male: yes	20	Phase 2	Slovenia

First Previous1Next Last